Objective: To assess evidence on the efficacy of adjuvant human papillomavirus (HPV)
vaccination in patients treated for HPV-related disease across different susceptible organ …

Objective: The aim of this meta-analysis was to discuss evidence supporting the efficacy of
adjuvant human papillomavirus (HPV) vaccination in reducing the risk of recurrent cervical …

Objective To explore the efficacy of human papillomavirus (HPV) vaccination on the risk of
HPV infection and recurrent diseases related to HPV infection in individuals undergoing …

We evaluated the efficacy of the human papillomavirus (HPV)− 16/18 AS04‐adjuvanted
vaccine in preventing HPV‐related disease after surgery for cervical lesions in a post‐hoc …

Objective The aim of this systematic review and meta-analysis was to review evidence
supporting the use of prophylactic human papillomavirus (HPV) vaccines to influence the …

Objective: To date, no data supports the execution of vaccination after hysterectomy for high-
grade cervical intraepithelial neoplasia (CIN2+) and early-stage cervical cancer. We aim to …

Aim Human papillomavirus (HPV) is the etiologic agent of the majority of cervical
intraepithelial lesions (CIN) and cervical cancers. While prophylactic HPV vaccines prevent …

Background Human papillomavirus (HPV) infections are associated with common
dermatologic and nondermatologic diseases. Although HPV vaccines are well established …

Importance Human papillomavirus (HPV) vaccination is recommended for children and
younger adults but not older adults or those with prior HPV exposure, leaving a large portion …

Introduction Human papillomavirus (HPV) vaccination is essential for cervical cancer
prevention. However, the value of HPV vaccination in the context excisional treatment of …